Slovenian Intellectual Property Office SIPO Database Server Guide

 One record is selected
 Patent in force
(51)Int. Cl.:
A61K 31/00     
(11)Publication Number:2203462
(21)Application Number:200831244
(22)Application Date:26.03.2008
(86)PCT Application:26.03.2008 WO PCT/US2008/058183
(96)EP Application:26.03.2008 EP 08732818.3 European patent register
(87)PCT Publication:WO 2008/121634, 09.10.2008 Patentscope
(97)EP Publication: EP 2203462 B1, 21.05.2014 European publication server PDF
EP 2203462 B2, 25.09.2024 European publication server PDF
(30)Priority:30.03.2007 US 909315;
24.10.2007 US 982309;
21.03.2008 US 53015
(46)Claims Published:30.09.2014 (T1 - Translation of claims of European patent) PDF
(72)Inventor:SOFIA Michael Joseph, Doylestown, PA 18902, US (United States);
DU Jinfa, New Hope, PA 18938, US (United States);
WANG Peiyuan, Glen Rock, NJ 07452, US (United States);
NAGARATHNAM Dhanapalan, Bethany, CT 06524, US (United States)
(73)Owner:Gilead Pharmasset LLC,
Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, US (United States)
(74)Representative:Marjan Pipan, inz. el.,
Kotnikova 5, 1000 Ljubljana, SI (Slovenia)
(54)Title:NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
Additional information: 
 Filed by SIPO on 18.07.2014
 SPC request date: 17.11.2014
 SPC application(s):  201440043
 Renewal fee for the patent for the 19th year is due on 26.03.2026